Cargando…

Tapentadol extended release for the management of chronic neck pain

BACKGROUND: The role of opioids in the management of chronic neck pain is still poorly investigated. No data are available on tapentadol extended release (ER). In this article, we present 54 patients with moderate-to-severe chronic neck pain treated with tapentadol ER. PATIENTS AND METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Billeci, Domenico, Coluzzi, Flaminia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338932/ https://www.ncbi.nlm.nih.gov/pubmed/28280384 http://dx.doi.org/10.2147/JPR.S129056

Ejemplares similares

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease
por: Coluzzi, Flaminia, et al.
Publicado: (2015)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy
por: Schwartz, Sherwyn, et al.
Publicado: (2014)

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study
por: Steigerwald, Ilona, et al.
Publicado: (2012)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
por: Haeseler, Gertrud, et al.
Publicado: (2017)

Diversion and Illicit Sale of Extended Release Tapentadol in the United States
por: Dart, Richard C., et al.
Publicado: (2016)

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
por: Samolsky Dekel, Boaz G., et al.
Publicado: (2015)

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release
por: Imanaka, Keiichiro, et al.
Publicado: (2014)

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain
por: Steigerwald, Ilona, et al.
Publicado: (2013)

Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
por: Coluzzi, Flaminia, et al.
Publicado: (2020)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol immediate release: a new treatment option for acute pain management
por: Afilalo, Marc, et al.
Publicado: (2010)

Endoscopic Transforaminal Lumbar Foraminotomy: A Systematic Review and Meta-Analysis
por: Giordan, Enrico, et al.
Publicado: (2021)

Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
por: Coluzzi, Flaminia, et al.
Publicado: (2022)

Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients
por: Schikowski, Artur, et al.
Publicado: (2014)

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain
por: Kress, H.G., et al.
Publicado: (2016)

Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis
por: Biondi, David M., et al.
Publicado: (2014)

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016
por: Zah, Vladimir, et al.
Publicado: (2019)

Full-endoscopic transpedicular discectomy (FETD) for lumbar herniations: Case report and review of the literature
por: Giordan, Enrico, et al.
Publicado: (2020)

Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality
por: Vellucci, Renato, et al.
Publicado: (2021)

Acute postoperative pain management: focus on iontophoretic transdermal fentanyl
por: Mattia, Consalvo, et al.
Publicado: (2007)

Chronic non-cancer pain: Focus on once-daily tramadol formulations
por: Coluzzi, Flaminia, et al.
Publicado: (2007)

Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data
por: Schwittay, Andreas, et al.
Publicado: (2020)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
por: Pergolizzi, Joseph, et al.
Publicado: (2011)

Pain Management in Patients with Multiple Myeloma: An Update
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Tramadol extended-release in the management of chronic pain
por: McCarberg, Bill
Publicado: (2007)

Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes
por: Tedeschi, Anna, et al.
Publicado: (2018)

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson’s disease
por: Freo, Ulderico, et al.
Publicado: (2018)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_52tvs1c06n0trvp0ahru01kr6v